GlassScriptPhysician profile
Sonali Dhir
NPI 1760981237
$5,405.43
in general payments reported to CMS, 2019-2025
53 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,531 · 2022: $886 · 2023: $1,200 · 2024: $461 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,630 · Education: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,629.67 |
| Education | $358.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $560.26 | 2021-2025 | Darzalex, Talvey, Tecvayli |
| Incyte Corporation | $539.72 | 2021-2025 | Jakafi |
| E.R. Squibb & Sons, L.L.C. | $368.13 | 2021-2025 | Opdivo, Reblozyl, Opdualag |
| Astrazeneca Pharmaceuticals LP | $296.31 | 2021-2025 | Tagrisso, Enhertu, Tezspire |
| Merck Sharp & Dohme LLC | $266.07 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Novartis Pharmaceuticals Corporation | $265.16 | 2021-2025 | |
| Daiichi Sankyo INC. | $254.10 | 2021-2025 | Enhertu, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $235.62 | 2021-2025 | |
| Astellas Pharma US INC | $222.68 | 2021-2024 | Xtandi, Padcev |
| Glaxosmithkline, LLC. | $208.72 | 2021-2025 | Nucala, Blenrep, Ojjaara |
| Seagen INC. | $163.57 | 2021-2022 | |
| Amgen INC. | $162.00 | 2021-2023 | Kyprolis, Vectibix, Xgeva |
| Pharmacyclics LLC, An Abbvie Company | $155.84 | 2021-2022 | |
| Gilead Sciences, INC. | $155.55 | 2022-2023 | Trodelvy |
| Abbvie INC. | $147.28 | 2021-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $115.40 | 2023-2024 | |
| Pharmacosmos Therapeutics INC. | $100.52 | 2025 | Monoferric |
| Eisai INC. | $100.16 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $89.00 | 2021 | |
| Epizyme, INC. | $78.51 | 2021-2022 | |
| Celgene Corporation | $69.82 | 2021-2025 | Reblozyl, Opdualag |
| Genzyme Corporation | $56.06 | 2021 | |
| Lilly USA, LLC | $55.72 | 2021-2023 | Jaypirca, Verzenio |
| United Therapeutics Corporation | $48.99 | 2024 | Orenitram, Remodulin, Tyvaso |
| Pfizer INC. | $46.87 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $43.37 | 2021-2025 | |
| Rigel Pharmaceuticals, INC. | $41.43 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $36.66 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $34.36 | 2025 | Libtayo, Lynozyfic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.57 | 2023 | Ofev |
| Aveo Pharmaceuticals, INC. | $31.79 | 2022 | |
| Harmony Biosciences LLC | $30.11 | 2023-2024 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $29.46 | 2022 | |
| Sun Pharmaceutical Industries INC. | $29.34 | 2021 | |
| Emd Serono, INC. | $29.28 | 2021-2022 | |
| Coherus Oncology, INC. | $28.04 | 2021-2023 | |
| Medtronic, INC. | $24.70 | 2024 | Signia |
| Becton, Dickinson and Company | $22.91 | 2024 | Phasix Mesh |
| Pulmonx Corporation | $21.28 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Agios Pharmaceuticals, INC. | $17.71 | 2025 | Pyrukynd |
| Eusa Pharma (US) LLC | $17.53 | 2021 | |
| Solventum Corporation | $16.07 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Pharming Healthcare, INC. | $16.01 | 2023 | Ruconest |
| Blue Earth Diagnostics | $16.01 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.63 | 2024 | Iovera, Exparel |
| Integra Lifesciences Corporation | $15.29 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Octapharma USA, INC. | $14.75 | 2022 | |
| Morphosys, US INC. | $14.35 | 2021 | |
| Fresenius Kabi USA, LLC | $13.66 | 2022 | |
| Servier Pharmaceuticals LLC | $13.49 | 2021 | |
| Puma Biotechnology, INC. | $13.21 | 2022 | |
| Myovant Sciences INC. | $13.09 | 2021 | |
| Array Biopharma INC | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonali Dhir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.